Investors deemed vulnerable if Sigma/CWH deal fails

Analyst warns Sigma share price could take a hit if Chemist Warehouse merger is blocked Sigma Healthcare investors could be exposed to downside risk if the competition watchdog doesn’t approve the proposed merger with Chemist Warehouse (CWH), given it has largely been priced in by the market already, an analyst believes. Australia’s competition watchdog is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Another year of free flu shots in the West
Next Bringing menopause out of the shadows